[1] Reutfors J., Cesta C.E., Cohen J.M., Bateman T., Brauer R., Einarsdóttir K., Engeland A., Furu K., Gissler M., Havard A., Hernandez-Diaz S., Huybrechts K.F., Karlstad Q., Leinonen M.K., Li J., Man K., Pazzagli L., Schaffer A., Schink T., Wang Z., Yu Y., Zoega H., Bröms G,
Antipsychotic Drug Use in Pregnancy: A Multinational Study from Ten Countries,
Schizophrenia Research,
220: 106-115 (2020).
[9] Wu Z.Y., Huang S., Zou J., Wang Q., Naveed M., Bao H., Wang W., Fukunaga K ., Han F,
Autism Spectrum Disorder (ASD): Disturbance of the Melatonin System and its Implications,
Biomedicine & Pharmacotherapy,
130: 110496 (2020).
[13] Hwang P.L., Wei S.Y., Yeh H.H., Ko J.Y., Chang C.C., Chen S.H.,
Simultaneous Determination of Aripiprazole and its Active Metabolite, Dehydroaripiprazole, in Plasma by Capillary Electrophoresis Combining On-Column Fieldamplified Sample Injection and Application in Schizophrenia,
Electrophoresis,
31: 2778-2786 (2010).
[15] Vignali C., Freni F., Magnani C., Moretti M., Siodambro C., Groppi A., Maria Osculati A.M., Morini L.,
Distribution of Quetiapine and Metabolites in Biological Fluids and Tissues,
Forensic Science International, 307: 110108 (2020).
[21] Tonooka K., Yoshida L., Tomobe K., Kunisue Y., Terada M., Shinozuka T.,
Sensitive Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Determination of Risperidone, Olanzapine, Quetiapine, Clozapine, Ziprasidone, Perospirone, Aripiprazole and Blonanserin in Human Serum,
American Journal of Analytical Chemistry,
9: 88-97 (2018).
[23] Chen X., Liang C., Cui L., Le J., Qian Z., Zhang R., Hong Z., Chai Y.,
A Rapid LC-MS/MS Method for Simultaneous Determination of Quetiapine and Duloxetine in Rat Plasma and its Application to Pharmacokinetic Interaction Study,
Journal of Food and Drug Analysis,
27: 323-331 (2019).
[32] Sastry B.S., Gananadhamu S., Devalarao G., RP-HPLC Determination of Aripiprazole in Pharmaceutical Formulations. Asian Journal of Chemistry. 21: 6643-6646 (2009).